Regional Regulatory Lead
Speichern Sie diesen Job und halten Sie Ihre Suche organisiert
Erstellen Sie ein kostenloses Konto, um Jobs zu speichern, Benachrichtigungen zu erstellen und von Ihrem Dashboard aus zu diesem Eintrag zurückzukehren.
Wenn Sie fortfahren, akzeptieren Sie unsere Nutzungsbedingungen & Datenschutzerklärung.
The Regional Regulatory Lead (RRL) is responsible for both strategic and operational regulatory activities within the assigned Therapeutic Area (TA) for designated products across designated regions or sub-regions: Asia Pacific (APAC), Latin America (LATAM), Commonwealth of Independent States (CIS), Adriatics, Middle East & Africa (MEA) and Partner Business. The RPL can be based at either of the following sites: Zurich (Switzerland), or Maidenhead (UK).
Working with the Therapeutic Area Lead and the Global Regulatory Lead, the RRL contributes to global regulatory strategy and manages regional regulatory strategies that align with commercial and business priorities.
This position ensures adherence to regional regulatory requirements and oversees submissions related to marketing applications, life cycle management, tender applications, interactions with Health Authorities, PSURs, and associated reporting responsibilities. The RRL partners with Local Regulatory Representative (LRR), Regulatory Partner Representative (RPR), and other internal stakeholders to facilitate timely Health Authority approvals.
Key Responsibilities
Your Profile
Why Join Us?
This is a unique opportunity to contribute to the delivery of life-changing therapies to patients worldwide while working within a collaborative and innovative global environment.
At CSL, we are committed to continuous improvement, scientific excellence, and making a meaningful difference in patients’ lives.
We are looking forward to receiving your online application. Applications must include a motivation letter and CV.
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene